Meet us at the ESGCT 2019 in Barcelona, Spain, Oct 22 - 25, 2019.
Meet us at the Cell & Gene Therapy Congress in London, UK, Oct 29 - 30, 2019.
Meet us at the Gene Therapy Analytical Development Conference in Boston, USA, Nov 19 - 21, 2019.
Meet us at the MEDICA in Düsseldorf, GER, Nov 18 - 21, 2019.
Extensive licenses for AAV research antibodies and ELISA test systems strengthen PROGEN´s position in the gene therapy market.
Katja Betts and Maik Lander follow former General Manager Dr. Sven Kuhlendahl as new Managing Directors.
PROGEN now offers prohisto IHC staining kits for relaxed IHC handling!
35 years after PROGEN was founded by scientists of the German Cancer Research Center (DKFZ) and the University of Heidelberg in 1983, the company...
PROGENs Head of Research & Development gives you an insight on how PROGEN validates its antibodies and what to consider to make the right antibody...
For the second time since 2016, PROGEN has received the research award "Innovativ durch Forschung"
Adeno-associated-viruses (AAV) are powerful tools in gene therapy
PROGEN has been "highly commended" in the antibody validation initative award category in the 2018 CiteAb Awards.
PROGEN has acquired EuroProxima’s research antibodies to supplement its cell biology portfolio, among them a selection of keratin and hormone...
PEPperPRINT are pleased to announce the development of a new biomarker test for early diagnosis of rheumatoid arthritis in cooperation with PROGEN...
